Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Molecular Autopsy Implicates Primary Carnitine Deficiency in Sudden Unexplained Death and Reversible Short QT Syndrome.

Gélinas R, Leach E, Horvath G, Laksman Z.

Can J Cardiol. 2019 Sep;35(9):1256.e1-1256.e2. doi: 10.1016/j.cjca.2019.05.014. Epub 2019 May 16.

PMID:
31472821
2.

AMP-Activated Protein Kinase and O-GlcNAcylation, Two Partners Tightly Connected to Regulate Key Cellular Processes.

Gélinas R, Dontaine J, Horman S, Beauloye C, Bultot L, Bertrand L.

Front Endocrinol (Lausanne). 2018 Sep 13;9:519. doi: 10.3389/fendo.2018.00519. eCollection 2018. Review.

3.

AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation.

Gélinas R, Mailleux F, Dontaine J, Bultot L, Demeulder B, Ginion A, Daskalopoulos EP, Esfahani H, Dubois-Deruy E, Lauzier B, Gauthier C, Olson AK, Bouchard B, Des Rosiers C, Viollet B, Sakamoto K, Balligand JL, Vanoverschelde JL, Beauloye C, Horman S, Bertrand L.

Nat Commun. 2018 Jan 25;9(1):374. doi: 10.1038/s41467-017-02795-4.

4.

Characterization of a Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for the Study of Variant Pathogenicity: Validation of a KCNJ2 Mutation.

Gélinas R, El Khoury N, Chaix MA, Beauchamp C, Alikashani A, Ethier N, Boucher G, Villeneuve L, Robb L, Latour F, Mondesert B, Rivard L, Goyette P, Talajic M, Fiset C, Rioux JD.

Circ Cardiovasc Genet. 2017 Oct;10(5). pii: e001755. doi: 10.1161/CIRCGENETICS.117.001755.

PMID:
29021306
5.

Metabolism and acetylation contribute to leucine-mediated inhibition of cardiac glucose uptake.

Renguet E, Ginion A, Gélinas R, Bultot L, Auquier J, Robillard Frayne I, Daneault C, Vanoverschelde JL, Des Rosiers C, Hue L, Horman S, Beauloye C, Bertrand L.

Am J Physiol Heart Circ Physiol. 2017 Aug 1;313(2):H432-H445. doi: 10.1152/ajpheart.00738.2016. Epub 2017 Jun 23.

6.

TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT.

Devalla HD, Gélinas R, Aburawi EH, Beqqali A, Goyette P, Freund C, Chaix MA, Tadros R, Jiang H, Le Béchec A, Monshouwer-Kloots JJ, Zwetsloot T, Kosmidis G, Latour F, Alikashani A, Hoekstra M, Schlaepfer J, Mummery CL, Stevenson B, Kutalik Z, de Vries AA, Rivard L, Wilde AA, Talajic M, Verkerk AO, Al-Gazali L, Rioux JD, Bhuiyan ZA, Passier R.

EMBO Mol Med. 2016 Dec 1;8(12):1390-1408. doi: 10.15252/emmm.201505719. Print 2016 Dec.

7.

O-GlcNAcylation, enemy or ally during cardiac hypertrophy development?

Mailleux F, Gélinas R, Beauloye C, Horman S, Bertrand L.

Biochim Biophys Acta. 2016 Dec;1862(12):2232-2243. doi: 10.1016/j.bbadis.2016.08.012. Epub 2016 Aug 17. Review.

8.

Reduction in Na(+) current by angiotensin II is mediated by PKCα in mouse and human-induced pluripotent stem cell-derived cardiomyocytes.

Mathieu S, El Khoury N, Rivard K, Gélinas R, Goyette P, Paradis P, Nemer M, Fiset C.

Heart Rhythm. 2016 Jun;13(6):1346-54. doi: 10.1016/j.hrthm.2016.02.015. Epub 2016 Feb 24.

PMID:
26921763
9.

A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51.

Ameziane N, May P, Haitjema A, van de Vrugt HJ, van Rossum-Fikkert SE, Ristic D, Williams GJ, Balk J, Rockx D, Li H, Rooimans MA, Oostra AB, Velleuer E, Dietrich R, Bleijerveld OB, Maarten Altelaar AF, Meijers-Heijboer H, Joenje H, Glusman G, Roach J, Hood L, Galas D, Wyman C, Balling R, den Dunnen J, de Winter JP, Kanaar R, Gelinas R, Dorsman JC.

Nat Commun. 2015 Dec 18;6:8829. doi: 10.1038/ncomms9829.

10.

A systems approach to understanding human rhinovirus and influenza virus infection.

Kim TK, Bheda-Malge A, Lin Y, Sreekrishna K, Adams R, Robinson MK, Bascom CC, Tiesman JP, Isfort RJ, Gelinas R.

Virology. 2015 Dec;486:146-57. doi: 10.1016/j.virol.2015.08.014. Epub 2015 Oct 6.

11.

Metabolic Tracing Using Stable Isotope-Labeled Substrates and Mass Spectrometry in the Perfused Mouse Heart.

Ruiz M, Gélinas R, Vaillant F, Lauzier B, Des Rosiers C.

Methods Enzymol. 2015;561:107-47. doi: 10.1016/bs.mie.2015.06.026. Epub 2015 Aug 17. Review.

PMID:
26358903
12.

Rare variants in neuronal excitability genes influence risk for bipolar disorder.

Ament SA, Szelinger S, Glusman G, Ashworth J, Hou L, Akula N, Shekhtman T, Badner JA, Brunkow ME, Mauldin DE, Stittrich AB, Rouleau K, Detera-Wadleigh SD, Nurnberger JI Jr, Edenberg HJ, Gershon ES, Schork N; Bipolar Genome Study, Price ND, Gelinas R, Hood L, Craig D, McMahon FJ, Kelsoe JR, Roach JC.

Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3576-81. doi: 10.1073/pnas.1424958112. Epub 2015 Feb 17.

13.

Mouse hair cycle expression dynamics modeled as coupled mesenchymal and epithelial oscillators.

Tasseff R, Bheda-Malge A, DiColandrea T, Bascom CC, Isfort RJ, Gelinas R.

PLoS Comput Biol. 2014 Nov 6;10(11):e1003914. doi: 10.1371/journal.pcbi.1003914. eCollection 2014 Nov.

14.

Protein and microRNA biomarkers from lavage, urine, and serum in military personnel evaluated for dyspnea.

Brown JN, Brewer HM, Nicora CD, Weitz KK, Morris MJ, Skabelund AJ, Adkins JN, Smith RD, Cho JH, Gelinas R.

BMC Med Genomics. 2014 Oct 5;7:58. doi: 10.1186/1755-8794-7-58.

15.

A-769662 potentiates the effect of other AMP-activated protein kinase activators on cardiac glucose uptake.

Timmermans AD, Balteau M, Gélinas R, Renguet E, Ginion A, de Meester C, Sakamoto K, Balligand JL, Bontemps F, Vanoverschelde JL, Horman S, Beauloye C, Bertrand L.

Am J Physiol Heart Circ Physiol. 2014 Jun 15;306(12):H1619-30. doi: 10.1152/ajpheart.00965.2013. Epub 2014 Apr 18.

16.

Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signaling.

Shaw S, Bourne T, Meier C, Carrington B, Gelinas R, Henry A, Popplewell A, Adams R, Baker T, Rapecki S, Marshall D, Moore A, Neale H, Lawson A.

MAbs. 2014 May-Jun;6(3):774-82. doi: 10.4161/mabs.28612. Epub 2014 Apr 2.

17.

Mouse strain differences in metabolic fluxes and function of ex vivo working hearts.

Vaillant F, Lauzier B, Poirier I, Gélinas R, Rivard ME, Robillard Frayne I, Thorin E, Des Rosiers C.

Am J Physiol Heart Circ Physiol. 2014 Jan 1;306(1):H78-87. doi: 10.1152/ajpheart.00465.2013. Epub 2013 Nov 1.

18.

Metabolic effects of glutamine on the heart: anaplerosis versus the hexosamine biosynthetic pathway.

Lauzier B, Vaillant F, Merlen C, Gélinas R, Bouchard B, Rivard ME, Labarthe F, Dolinsky VW, Dyck JR, Allen BG, Chatham JC, Des Rosiers C.

J Mol Cell Cardiol. 2013 Feb;55:92-100. doi: 10.1016/j.yjmcc.2012.11.008. Epub 2012 Nov 28.

19.

Gene expression networks in COPD: microRNA and mRNA regulation.

Ezzie ME, Crawford M, Cho JH, Orellana R, Zhang S, Gelinas R, Batte K, Yu L, Nuovo G, Galas D, Diaz P, Wang K, Nana-Sinkam SP.

Thorax. 2012 Feb;67(2):122-31. doi: 10.1136/thoraxjnl-2011-200089. Epub 2011 Sep 22.

PMID:
21940491
20.

Interleukin-6 contributes to inflammation and remodeling in a model of adenosine mediated lung injury.

Pedroza M, Schneider DJ, Karmouty-Quintana H, Coote J, Shaw S, Corrigan R, Molina JG, Alcorn JL, Galas D, Gelinas R, Blackburn MR.

PLoS One. 2011;6(7):e22667. doi: 10.1371/journal.pone.0022667. Epub 2011 Jul 25.

21.

Prolonged QT interval and lipid alterations beyond β-oxidation in very long-chain acyl-CoA dehydrogenase null mouse hearts.

Gélinas R, Thompson-Legault J, Bouchard B, Daneault C, Mansour A, Gillis MA, Charron G, Gavino V, Labarthe F, Des Rosiers C.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H813-23. doi: 10.1152/ajpheart.01275.2010. Epub 2011 Jun 17.

22.

Ivabradine reduces heart rate while preserving metabolic fluxes and energy status of healthy normoxic working hearts.

Lauzier B, Vaillant F, Gélinas R, Bouchard B, Brownsey R, Thorin E, Tardif JC, Des Rosiers C.

Am J Physiol Heart Circ Physiol. 2011 Mar;300(3):H845-52. doi: 10.1152/ajpheart.01034.2010. Epub 2011 Jan 21.

23.

Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes.

Cho JH, Gelinas R, Wang K, Etheridge A, Piper MG, Batte K, Dakhallah D, Price J, Bornman D, Zhang S, Marsh C, Galas D.

BMC Med Genomics. 2011 Jan 17;4:8. doi: 10.1186/1755-8794-4-8.

24.

A genetic approach to the prediction of drug side effects: bleomycin induces concordant phenotypes in mice of the collaborative cross.

Gelinas R, Chesler EJ, Vasconcelos D, Miller DR, Yuan Y, Wang K, Galas D.

Pharmgenomics Pers Med. 2011;4:35-45. doi: 10.2147/PGPM.S22475. Epub 2011 Jul 4.

25.

Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats.

Ménard SL, Croteau E, Sarrhini O, Gélinas R, Brassard P, Ouellet R, Bentourkia M, van Lier JE, Des Rosiers C, Lecomte R, Carpentier AC.

Am J Physiol Endocrinol Metab. 2010 May;298(5):E1049-57. doi: 10.1152/ajpendo.00560.2009. Epub 2010 Feb 16.

26.

Integrating the MicroRNome into the study of lung disease.

Nana-Sinkam SP, Hunter MG, Nuovo GJ, Schmittgen TD, Gelinas R, Galas D, Marsh CB.

Am J Respir Crit Care Med. 2009 Jan 1;179(1):4-10. doi: 10.1164/rccm.200807-1042PP. Epub 2008 Sep 11. Review.

27.

Cyclic GMP signaling in cardiomyocytes modulates fatty acid trafficking and prevents triglyceride accumulation.

Khairallah RJ, Khairallah M, Gélinas R, Bouchard B, Young ME, Allen BG, Lopaschuk GD, Deschepper CF, Des Rosiers C.

J Mol Cell Cardiol. 2008 Aug;45(2):230-9. doi: 10.1016/j.yjmcc.2008.05.012. Epub 2008 May 27.

28.

Medium-chain fatty acids as metabolic therapy in cardiac disease.

Labarthe F, Gélinas R, Des Rosiers C.

Cardiovasc Drugs Ther. 2008 Apr;22(2):97-106. doi: 10.1007/s10557-008-6084-0. Review.

PMID:
18253821
29.

Alterations in carbohydrate metabolism and its regulation in PPARalpha null mouse hearts.

Gélinas R, Labarthe F, Bouchard B, Mc Duff J, Charron G, Young ME, Des Rosiers C.

Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1571-80. doi: 10.1152/ajpheart.01340.2007. Epub 2008 Jan 25.

30.

A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease.

Puleston J, Cooper M, Murch S, Bid K, Makh S, Ashwood P, Bingham AH, Green H, Moss P, Dhillon A, Morris R, Strobel S, Gelinas R, Pounder RE, Platt A.

Aliment Pharmacol Ther. 2005 Jan 15;21(2):109-20.

31.

Benzobicyclooctanes as novel inhibitors of TNF-alpha signaling.

Jackson RW, Gelinas R, Baughman TA, Cox T, Howbert JJ, Kucera KA, Latham JA, Ramsdell F, Singh D, Darwish IS.

Bioorg Med Chem Lett. 2002 Apr 8;12(7):1093-7.

PMID:
11909725
32.

An amazing sequence arrangement at the 5' ends of adenovirus 2 messenger RNA. 1977.

Chow LC, Gelinas RE, Broker TR, Roberts RJ.

Rev Med Virol. 2000 Nov-Dec;10(6):362-71; discussion 355-6. No abstract available.

PMID:
11187030
33.

Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression.

Nelson PS, Gan L, Ferguson C, Moss P, Gelinas R, Hood L, Wang K.

Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3114-9.

34.

Identification and characterisation of a human calmodulin-stimulated phosphodiesterase PDE1B1.

Yu J, Wolda SL, Frazier AL, Florio VA, Martins TJ, Snyder PB, Harris EA, McCaw KN, Farrell CA, Steiner B, Bentley JK, Beavo JA, Ferguson K, Gelinas R.

Cell Signal. 1997 Nov;9(7):519-29.

PMID:
9419816
35.

The repertoire of T cell antigen receptor beta-chain variable regions associated with psoriasis vulgaris.

Moss P, Charmley P, Mulvihill E, Ziegler S, Raugi GJ, Kern D, Piepkorn M, Gelinas R.

J Invest Dermatol. 1997 Jul;109(1):14-9.

36.

Sequences located 3' to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal A gamma-globin gene in transgenic mice.

Anagnou NP, Perez-Stable C, Gelinas R, Costantini F, Liapaki K, Constantopoulou M, Kosteas T, Moschonas NK, Stamatoyannopoulos G.

J Biol Chem. 1995 Apr 28;270(17):10256-63.

37.

A normal level of beta-globin expression in erythroid cells after retroviral cells transfer.

Gelinas R, Frazier A, Harris E.

Bone Marrow Transplant. 1992;9 Suppl 1:154-7. No abstract available.

PMID:
1504659
38.
39.

The search for evidence of large prehistoric earthquakes along the atlantic seaboard.

Amick D, Gelinas R.

Science. 1991 Feb 8;251(4994):655-8.

PMID:
17741382
40.

Expression of the human gamma-globin gene after retroviral transfer to transformed erythroid cells.

Rixon MW, Harris EA, Gelinas RE.

Biochemistry. 1990 May 8;29(18):4393-400.

PMID:
1693523
41.
42.
43.

Human brain glycogen phosphorylase: characterization of fetal cDNA and genomic sequences.

Gelinas RP, Froman BE, McElroy F, Tait RC, Gorin FA.

Brain Res Mol Brain Res. 1989 Nov;6(2-3):177-85.

PMID:
2615594
44.

Abnormal expression of glycogen phosphorylase genes in regenerated muscle.

Gorin F, Ignacio P, Gelinas R, Carlsen R.

Am J Physiol. 1989 Sep;257(3 Pt 1):C495-503.

PMID:
2528910
45.

Molecular analysis of the human beta-globin locus activation region.

Forrester WC, Novak U, Gelinas R, Groudine M.

Proc Natl Acad Sci U S A. 1989 Jul;86(14):5439-43.

46.

The human growth hormone locus: nucleotide sequence, biology, and evolution.

Chen EY, Liao YC, Smith DH, Barrera-Saldaña HA, Gelinas RE, Seeburg PH.

Genomics. 1989 May;4(4):479-97.

PMID:
2744760
48.
49.
50.

Design of retrovirus vectors for transfer and expression of the human beta-globin gene.

Miller AD, Bender MA, Harris EA, Kaleko M, Gelinas RE.

J Virol. 1988 Nov;62(11):4337-45. Erratum in: J Virol 1989 Mar;63(3):1493.

Supplemental Content

Loading ...
Support Center